Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Immune reconstitution is preserved in hematopoietic stem cell transplantation coadministered with regulatory T cells for GVHD prevention.

Gaidot A, Landau DA, Martin GH, Bonduelle O, Grinberg-Bleyer Y, Matheoud D, Grégoire S, Baillou C, Combadière B, Piaggio E, Cohen JL.

Blood. 2011 Mar 10;117(10):2975-83. doi: 10.1182/blood-2010-08-299974. Epub 2010 Dec 30.

2.

Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.

Chen G, Wu D, Wang Y, Cen J, Feng Y, Sun A, Tang X, Chang H, Zhu Z.

Eur J Haematol. 2008 Sep;81(3):226-35. doi: 10.1111/j.1600-0609.2008.01108.x. Epub 2008 Jun 28.

PMID:
18573173
5.

Inhibition of graft-versus-host disease by double-negative regulatory T cells.

Young KJ, DuTemple B, Phillips MJ, Zhang L.

J Immunol. 2003 Jul 1;171(1):134-41.

7.

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.

Di Ianni M, Falzetti F, Carotti A, Terenzi A, Castellino F, Bonifacio E, Del Papa B, Zei T, Ostini RI, Cecchini D, Aloisi T, Perruccio K, Ruggeri L, Balucani C, Pierini A, Sportoletti P, Aristei C, Falini B, Reisner Y, Velardi A, Aversa F, Martelli MF.

Blood. 2011 Apr 7;117(14):3921-8. doi: 10.1182/blood-2010-10-311894. Epub 2011 Feb 3.

8.

Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.

Wang XN, Haniffa MA, Holtick U, Collin MP, Jackson G, Hilkens CM, Holler E, Edinger M, Hoffmann P, Dickinson AM.

Transplantation. 2009 Jul 27;88(2):188-97. doi: 10.1097/TP.0b013e3181ac14ce.

PMID:
19623013
9.

Characterization of graft-versus-host disease in SCID mice and prevention by physicochemical stressors.

Sheng-Tanner X, McKerlie C, Spaner D.

Transplantation. 2000 Dec 27;70(12):1683-93.

PMID:
11152097
10.
11.

Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.

Turner BE, Kambouris ME, Sinfield L, Lange J, Burns AM, Lourie R, Atkinson K, Hart DN, Munster DJ, Rice AM.

Transplantation. 2008 Oct 15;86(7):968-76. doi: 10.1097/TP.0b013e3181874787.

PMID:
18852664
12.

Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.

Strober S.

Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. Epub 2007 Sep 10. Review.

PMID:
17827036
14.

Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells.

Trenado A, Sudres M, Tang Q, Maury S, Charlotte F, Grégoire S, Bonyhadi M, Klatzmann D, Salomon BL, Cohen JL.

J Immunol. 2006 Jan 15;176(2):1266-73.

16.

Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.

MacDonald KP, Rowe V, Filippich C, Thomas R, Clouston AD, Welply JK, Hart DN, Ferrara JL, Hill GR.

Blood. 2003 Mar 1;101(5):2033-42. Epub 2002 Oct 17.

17.

Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.

Tian Y, Deng YB, Huang YJ, Wang Y.

Immunol Invest. 2008;37(1):29-42. doi: 10.1080/08820130701410223.

PMID:
18214798
18.

New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells.

Waller EK, Boyer M.

Bone Marrow Transplant. 2000 May;25 Suppl 2:S20-4.

PMID:
10933181
19.

High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.

Rezvani K, Mielke S, Ahmadzadeh M, Kilical Y, Savani BN, Zeilah J, Keyvanfar K, Montero A, Hensel N, Kurlander R, Barrett AJ.

Blood. 2006 Aug 15;108(4):1291-7. Epub 2006 Apr 20.

20.

Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation.

Weinberg K, Blazar BR, Wagner JE, Agura E, Hill BJ, Smogorzewska M, Koup RA, Betts MR, Collins RH, Douek DC.

Blood. 2001 Mar 1;97(5):1458-66.

Supplemental Content

Support Center